National Institute of Mental Health; Notice of Meeting, 3802-3803 [2019-02127]

Download as PDF 3802 Federal Register / Vol. 84, No. 30 / Wednesday, February 13, 2019 / Notices Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD 20892, 301–435– 1719, ngkl@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 7, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–02124 Filed 2–12–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings khammond on DSKBBV9HB2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–16– 089: Imaging and Biomarkers for Early Cancer Detection (U01). Date: March 7, 2019. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Xiang-Ning Li, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5112, MSC 7854, Bethesda, MD 20892, 301–435– 1744, lixiang@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: BRAIN Initiative: Targeted BRAIN Circuits Projects. Date: March 14–15, 2019. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of VerDate Sep<11>2014 17:22 Feb 12, 2019 Jkt 247001 Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301–435– 1242, kgt@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Drug Abuse Dissertation Research. Date: March 14, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Jingsheng Tuo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5207, Bethesda, MD 20892, 301–451–8754, tuoj@ nei.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Overflow: Emerging Imaging Technologies in Neuroscience. Date: March 14, 2019. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Yvonne Bennett, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5199, MSC 7846, Bethesda, MD 20892, 301–379– 3793, bennetty@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Hematology. Date: March 14–15, 2019. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Katherine M. Malinda, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, 301–435– 0912, Katherine_Malinda@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research. Date: March 14, 2019. Time: 10:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Miriam Mintzer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3108, Bethesda, MD 20892, 301–523–0646, mintzermz@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 Dated: February 7, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–02122 Filed 2–12–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of an Interagency Autism Coordinating Committee (IACC or Committee) meeting. The purpose of the IACC meeting is to discuss business, agency updates, and issues related to autism spectrum disorder (ASD) research and services activities. The meeting will be open to the public and will be accessible by webcast and conference call. Close captioning is provided; for other disabilities accommodations see below. Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of meeting: Open Meeting. Date: Wednesday, July 24, 2019. Time: 9:00 a.m. to 5:00 p.m.* Eastern Time. * Approximate end time. Agenda: To discuss business, updates, and issues related to ASD research and services activities. Place: Neuroscience Center, 6001 Executive Blvd., Conference Room C and D, Rockville, MD 20892. Webcast Live: https://videocast.nih.gov. Conference Call Access: Dial: 888–677– 5726, Access code: 2077198. Cost: The meeting is free and open to the public. Registration: A registration web link will be posted on the IACC website (www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended to expedite check-in. Seating in the meeting room is limited to room capacity and on a first come, first served basis. Onsite registration will also be available. Deadlines: Notification of intent to present oral comments: Friday, July 12, 2019 by 5:00 p.m. ET. Submission of written/electronic statement for oral comments: Tuesday, July 16, 2019 by 5:00 p.m. ET. Submission of written comments: Tuesday, July 16, 2019 by 5:00 p.m. ET. Webcast Live Feedback Public comments: No preregistration required. For instructions, see https://iacc.hhs.gov/ meetings/iacc-meetings/live-feedback.shtml. For IACC Public Comment guidelines please see: https://iacc.hhs.gov/meetings/ public-comments/guidelines/. Access: White Flint Metro Station (Red Line). E:\FR\FM\13FEN1.SGM 13FEN1 Federal Register / Vol. 84, No. 30 / Wednesday, February 13, 2019 / Notices khammond on DSKBBV9HB2PROD with NOTICES Contact Person: Ms. Angelice Mitrakas, Office of Autism Research Coordination, National Institute of Mental Health, NIH, 6001 Executive Boulevard, Room 6182A, Bethesda, MD 20892–9669, Phone: 301–435– 9269, Email: IACCPublicInquiries@ mail.nih.gov. Public Comments: Any member of the public interested in presenting oral comments to the IACC must notify the Contact Person listed on this notice by 5:00 p.m. ET on Friday, July 12, 2019 with their request to present oral comments at the meeting, and a written/ electronic copy of the oral presentation/ statement must be submitted by 5:00 p.m. ET on Tuesday, July 16, 2019. A limited number of slots for oral comment are available, and in order to ensure that as many different individuals are able to present throughout the year as possible, any given individual only will be permitted to present oral comments once per calendar year (2019). Only one representative of an organization will be allowed to present oral comments in any given meeting; other representatives of the same group may provide written comments. If the oral comment session is full, individuals who could not be accommodated are welcome to provide written comments instead. Comments to be read or presented in the meeting will be assigned a 3–5 minute time slot depending on the number of comments, but a longer version may be submitted in writing for the record. Commenters going beyond their allotted time in the meeting may be asked to conclude immediately in order to allow other comments and presentations to proceed on schedule. Any interested person may submit written public comments to the IACC prior to the meeting by emailing the comments to IACCPublicInquiries@ mail.nih.gov or by submitting comments at the web link: https://iacc.hhs.gov/ meetings/public-comments/submit/ index.jsp by 5:00 p.m. ET on Tuesday, July 16, 2019. The comments should include the name, address, telephone number, and when applicable, the business or professional affiliation of the interested person. NIMH anticipates written public comments received by 5:00 p.m. ET on Tuesday, July 16, 2019 will be presented to the Committee prior to the meeting for the Committee’s consideration. Any written comments received after the 5:00 p.m. ET, Tuesday, July 16, 2019 deadline through Tuesday, July 23, 2019 will be provided to the Committee either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other VerDate Sep<11>2014 17:22 Feb 12, 2019 Jkt 247001 applicable Federal policies. All written public comments and oral public comment statements received by the deadlines for both oral and written public comments will be provided to the IACC for their consideration and will become part of the public record. Attachments of copyrighted publications are not permitted, but web links or citations for any copyrighted works cited may be provided. Individuals may also submit public comments to the IACC via a Live Feedback Form accessible from the webcast page on the day of the meeting from 9:00 a.m. ET to 11:00 a.m. ET. No pre-registration required. The link will be accessible on the NIH Videocast website at https://videocast.nih.gov and instructions are available on the IACC website: https://iacc.hhs.gov/meetings/ iacc-meetings/live-feedback.shtml. This format is best suited for brief questions and comments for the committee. Submissions will be provided to the IACC and will become a part of the public record. In the 2016–2017 IACC Strategic Plan, the IACC listed the ‘‘Spirit of Collaboration’’ as one of its core values, stating that, ‘‘We will treat others with respect, listen with open minds to the diverse views of people on the autism spectrum and their families, thoughtfully consider community input, and foster discussions where participants can comfortably where participants can comfortably offer opposing opinions.’’ In keeping with this core value, the IACC and the NIMH Office of Autism Research Coordination (OARC) ask that members of the public who provide public comments or participate in meetings of the IACC also seek to treat others with respect and consideration in their communications and actions, even when discussing issues of genuine concern or disagreement. Remote Access: The meeting will be open to the public through a conference call phone number and webcast live on the internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the webcast or conference call, please send an email to IACCPublicInquiries@ mail.nih.gov or call 240–668–0302. Disability Accommodations: All IACC Full Meetings provide Closed Captioning through the NIH videocast website. Remote CART is provided through a web application and will be available at all meetings; the application can be used on a laptop computer or mobile device. For details please inquire PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 3803 with the Contact Person listed on the notice. Individuals whose full participation in the meeting will require special accommodations (e.g., sign language, or interpreting services, etc.) must submit a request to the Contact Person listed on the notice at least seven (7) business days prior to the meeting. Such requests should include a detailed description of the accommodation needed and a way for the IACC to contact the requester if more information is needed to fill the request. Special requests should be made as early as possible; last minute requests may be made but may not be possible to accommodate. Security: Visitors will be asked to sign in and show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) at the meeting registration desk during the check-in process. Pre-registration is recommended. Seating will be limited to the room capacity and seats will be on a first come, first served basis, with expedited check-in for those who are pre-registered. Meeting schedule subject to change. Information about the IACC is available on the website: https:// www.iacc.hhs.gov. Dated: February 7, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–02127 Filed 2–12–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; PREVENT: E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 84, Number 30 (Wednesday, February 13, 2019)]
[Notices]
[Pages 3802-3803]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02127]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of an Interagency Autism Coordinating 
Committee (IACC or Committee) meeting.
    The purpose of the IACC meeting is to discuss business, agency 
updates, and issues related to autism spectrum disorder (ASD) research 
and services activities. The meeting will be open to the public and 
will be accessible by webcast and conference call.
    Close captioning is provided; for other disabilities accommodations 
see below.

    Name of Committee: Interagency Autism Coordinating Committee 
(IACC).
    Type of meeting: Open Meeting.
    Date: Wednesday, July 24, 2019.
    Time: 9:00 a.m. to 5:00 p.m.* Eastern Time. * Approximate end 
time.
    Agenda: To discuss business, updates, and issues related to ASD 
research and services activities.
    Place: Neuroscience Center, 6001 Executive Blvd., Conference 
Room C and D, Rockville, MD 20892.
    Webcast Live: https://videocast.nih.gov.
    Conference Call Access: Dial: 888-677-5726, Access code: 
2077198.
    Cost: The meeting is free and open to the public.
    Registration: A registration web link will be posted on the IACC 
website (www.iacc.hhs.gov) prior to the meeting. Pre-registration is 
recommended to expedite check-in. Seating in the meeting room is 
limited to room capacity and on a first come, first served basis. 
Onsite registration will also be available.
    Deadlines: Notification of intent to present oral comments: 
Friday, July 12, 2019 by 5:00 p.m. ET.
    Submission of written/electronic statement for oral comments: 
Tuesday, July 16, 2019 by 5:00 p.m. ET.
    Submission of written comments: Tuesday, July 16, 2019 by 5:00 
p.m. ET.
    Webcast Live Feedback Public comments: No preregistration 
required.
    For instructions, see https://iacc.hhs.gov/meetings/iacc-meetings/live-feedback.shtml.
    For IACC Public Comment guidelines please see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.
    Access: White Flint Metro Station (Red Line).

[[Page 3803]]

    Contact Person: Ms. Angelice Mitrakas, Office of Autism Research 
Coordination, National Institute of Mental Health, NIH, 6001 
Executive Boulevard, Room 6182A, Bethesda, MD 20892-9669, Phone: 
301-435-9269, Email: IACCPublicInquiries@mail.nih.gov.

    Public Comments: Any member of the public interested in presenting 
oral comments to the IACC must notify the Contact Person listed on this 
notice by 5:00 p.m. ET on Friday, July 12, 2019 with their request to 
present oral comments at the meeting, and a written/electronic copy of 
the oral presentation/statement must be submitted by 5:00 p.m. ET on 
Tuesday, July 16, 2019.
    A limited number of slots for oral comment are available, and in 
order to ensure that as many different individuals are able to present 
throughout the year as possible, any given individual only will be 
permitted to present oral comments once per calendar year (2019). Only 
one representative of an organization will be allowed to present oral 
comments in any given meeting; other representatives of the same group 
may provide written comments. If the oral comment session is full, 
individuals who could not be accommodated are welcome to provide 
written comments instead. Comments to be read or presented in the 
meeting will be assigned a 3-5 minute time slot depending on the number 
of comments, but a longer version may be submitted in writing for the 
record. Commenters going beyond their allotted time in the meeting may 
be asked to conclude immediately in order to allow other comments and 
presentations to proceed on schedule.
    Any interested person may submit written public comments to the 
IACC prior to the meeting by emailing the comments to 
IACCPublicInquiries@mail.nih.gov or by submitting comments at the web 
link: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp by 
5:00 p.m. ET on Tuesday, July 16, 2019. The comments should include the 
name, address, telephone number, and when applicable, the business or 
professional affiliation of the interested person. NIMH anticipates 
written public comments received by 5:00 p.m. ET on Tuesday, July 16, 
2019 will be presented to the Committee prior to the meeting for the 
Committee's consideration. Any written comments received after the 5:00 
p.m. ET, Tuesday, July 16, 2019 deadline through Tuesday, July 23, 2019 
will be provided to the Committee either before or after the meeting, 
depending on the volume of comments received and the time required to 
process them in accordance with privacy regulations and other 
applicable Federal policies. All written public comments and oral 
public comment statements received by the deadlines for both oral and 
written public comments will be provided to the IACC for their 
consideration and will become part of the public record. Attachments of 
copyrighted publications are not permitted, but web links or citations 
for any copyrighted works cited may be provided.
    Individuals may also submit public comments to the IACC via a Live 
Feedback Form accessible from the webcast page on the day of the 
meeting from 9:00 a.m. ET to 11:00 a.m. ET. No pre-registration 
required. The link will be accessible on the NIH Videocast website at 
https://videocast.nih.gov and instructions are available on the IACC 
website: https://iacc.hhs.gov/meetings/iacc-meetings/live-feedback.shtml. This format is best suited for brief questions and 
comments for the committee. Submissions will be provided to the IACC 
and will become a part of the public record.
    In the 2016-2017 IACC Strategic Plan, the IACC listed the ``Spirit 
of Collaboration'' as one of its core values, stating that, ``We will 
treat others with respect, listen with open minds to the diverse views 
of people on the autism spectrum and their families, thoughtfully 
consider community input, and foster discussions where participants can 
comfortably where participants can comfortably offer opposing 
opinions.'' In keeping with this core value, the IACC and the NIMH 
Office of Autism Research Coordination (OARC) ask that members of the 
public who provide public comments or participate in meetings of the 
IACC also seek to treat others with respect and consideration in their 
communications and actions, even when discussing issues of genuine 
concern or disagreement.
    Remote Access: The meeting will be open to the public through a 
conference call phone number and webcast live on the internet. Members 
of the public who participate using the conference call phone number 
will be able to listen to the meeting but will not be heard. If you 
experience any technical problems with the webcast or conference call, 
please send an email to IACCPublicInquiries@mail.nih.gov or call 240-
668-0302.
    Disability Accommodations: All IACC Full Meetings provide Closed 
Captioning through the NIH videocast website. Remote CART is provided 
through a web application and will be available at all meetings; the 
application can be used on a laptop computer or mobile device. For 
details please inquire with the Contact Person listed on the notice.
    Individuals whose full participation in the meeting will require 
special accommodations (e.g., sign language, or interpreting services, 
etc.) must submit a request to the Contact Person listed on the notice 
at least seven (7) business days prior to the meeting. Such requests 
should include a detailed description of the accommodation needed and a 
way for the IACC to contact the requester if more information is needed 
to fill the request. Special requests should be made as early as 
possible; last minute requests may be made but may not be possible to 
accommodate.
    Security: Visitors will be asked to sign in and show one form of 
identification (for example, a government-issued photo ID, driver's 
license, or passport) at the meeting registration desk during the 
check-in process. Pre-registration is recommended. Seating will be 
limited to the room capacity and seats will be on a first come, first 
served basis, with expedited check-in for those who are pre-registered.
    Meeting schedule subject to change.
    Information about the IACC is available on the website: https://www.iacc.hhs.gov.

    Dated: February 7, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-02127 Filed 2-12-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.